Journal Mobile Options
Table of Contents
Vol. 39, No. 2, 2012
Issue release date: September 2012
Section title: Original Paper
Neuroepidemiology 2012;39:109–115
(DOI:10.1159/000339248)

Guillain-Barré Syndrome Incidence in a Large United States Cohort (2000–2009)

Shui I.M. · Rett M.D. · Weintraub E. · Marcy M. · Amato A.A. · Sheikh S.I. · Ho D. · Lee G.M. · Yih W.K. · for the Vaccine Safety Datalink Research Team
aDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, bDepartment of Epidemiology, Harvard School of Public Health, cDepartment of Neurology, Brigham and Women’s Hospital and Harvard Medical School, and dDepartment of Laboratory Medicine and Division of Infectious Diseases, Children’s Hospital, Boston, Mass., eImmunization Safety Office, Division of Healthcare Quality and Promotion, Centers for Disease Control and Prevention, Atlanta, Ga., and fKaiser Permanente Southern California, Pasadena, Calif., USA

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 6/7/2011
Accepted: 4/26/2012
Published online: 7/28/2012

Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 4

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: http://www.karger.com/NED

Abstract

Background/Aim: We describe the incidence of Guillain-Barré syndrome (GBS) in a large United States cohort. Methods: Between 2000 and 2009, we identified visits with an ICD-9 code for GBS (357.0) from all persons with continuous enrollment for at least 1 year. The primary case definition was restricted to emergency department and inpatient visits. We calculated age-standardized rates and used multivariate Poisson regression to assess variation in rates by sex, age, season and year of diagnosis. We tabulated descriptive characteristics and the positive predictive value (PPV) for a subset of the visits with available medical record review. Results: 1,619 visits with the GBS ICD-9 code were identified from 50,290,898 person-years of observation. After considering the PPV (55%) for record-reviewed visits, the age-standardized incidence rate was approximately 1.72/100,000 person-years. The rate was 40% higher for males and increased by 50% for every 10-year increase in age. The rate was 15% higher in winter and spring compared with summer. Rates were higher in more recent years. Conclusions: GBS rates are higher in males and increase considerably with age. The potential reasons for differences in rates by season and the increased rates in more recent years should be further investigated.


  

Author Contacts

Irene M. Shui, MPH, ScD
677 Huntington Avenue
Boston, MA 02115 (USA)
Tel. +1 617 432 1050
E-Mail ishui@hsph.harvard.edu

  

Article Information

Grace M. Lee and W. Katherine Yih share senior authorship.

Received: June 7, 2011
Accepted: April 26, 2012
Published online: July 28, 2012
Number of Print Pages : 7
Number of Figures : 1, Number of Tables : 4, Number of References : 30

  

Publication Details

Neuroepidemiology

Vol. 39, No. 2, Year 2012 (Cover Date: September 2012)

Journal Editor: Feigin V.L. (Auckland)
ISSN: 0251-5350 (Print), eISSN: 1423-0208 (Online)

For additional information: http://www.karger.com/NED


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 6/7/2011
Accepted: 4/26/2012
Published online: 7/28/2012

Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 4

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: http://www.karger.com/NED


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.